Benefits and Risks Associated With Thrombolysis for Pulmonary Embolism
Author:
- 15 October 2014
- journal article
- other
- Published by American Medical Association (AMA)
- Vol. 312 (15) , 1589
Abstract
To the Editor The optimal treatment of intermediate-risk patients with pulmonary embolism (hemodynamically stable patients with right ventricular dysfunction or increased cardiac biomarkers) is an important issue, and the meta-analysis by Dr Chatterjee and colleagues1 showed a reduction in mortality with the use of thrombolysis compared with anticoagulation in this group of patients. However, in my opinion caution is due in interpreting these results.Keywords
This publication has 2 references indexed in Scilit:
- Fibrinolysis for Patients with Intermediate-Risk Pulmonary EmbolismNew England Journal of Medicine, 2014
- Heparin plus Alteplase Compared with Heparin Alone in Patients with Submassive Pulmonary EmbolismNew England Journal of Medicine, 2002